GMP Insiders - Your trusted source for GMP compliance!

Subscribe

GMP Insiders logo
GMP Insiders logo
GMP Insiders logo

Tag: Cleaning Validation

RETURN HOME

If you don’t find what you are looking for, try using a different term or contact us.

Featured image for a GMP Insiders news article on EMA's Q&A guidance for microbial contamination control in non-sterile medicinal products. The graphic shows regulatory documents clipped together, representing new EMA expectations for contamination control, cleaning validation, and quality risk management in pharmaceutical manufacturing.

EMA Issues Q&A Guidance on Technical and Organizational Controls for Microbial Contamination in Non-Sterile Medicinal Products

The European Medicines Agency has published a new Q&A clarifying GMP expectations for preventing microbial contamination in non-sterile medicinal products....
Read more >>
Cleanroom equipment with text overlay showing comparison of qualification and validation in GMP.

Qualification vs Validation: Key Differences in GMP

Qualification vs. Validation explained for GMP professionals — clear regulatory differences, lifecycle expectations, and real-world applications across pharma systems....
Read more >>
clean hold time vs dirty hold time studies in cleaning validation - featured image

Clean Hold Time (CHT) and Dirty Hold Time (DHT) Studies in Cleaning Validation

Explore the critical role of Clean Hold Time (CHT) and Dirty Hold Time (DHT) in cleaning validation. This in-depth guide...
Read more >>
Contamination Control Strategy Featured Image

Risk-Based Contamination Control Strategy (CCS)

Learn how to build a risk-based Contamination Control Strategy (CCS) that meets Annex 1 (2022) expectations. Discover the key elements,...
Read more >>
fda-warning-letter-analysis

FDA Warning Letter Analysis: Chem-Tech, Ltd. – Deficiencies in OOS Investigation, Cleaning Validation and More

FDA issues a warning letter to Chem-Tech, Ltd. for improper OOS investigations, unvalidated cleaning procedures, and poor quality oversight. Key...
Read more >>
fda-warning-letter-analysis

FDA Issues Warning Letter to Strukmyer Medical Highlighting Serious CGMP Deficiencies

On January 30, 2025, the FDA issued a Warning Letter (320-25-37) to Strukmyer LLC dba Strukmyer Medical, following an inspection...

Read more >>
Validation Master Plan (VMP) In the Pharmaceutical Industry

Validation Master Plan (VMP) In the Pharmaceutical Industry

Learn how to create a comprehensive Validation Master Plan (VMP) to ensure consistent product quality and regulatory compliance...
Read more >>
Worst Case Selection in Cleaning Validation

Worst Case Selection in Cleaning Validation

Optimize cleaning validation in pharmaceutical manufacturing with key strategies for selecting worst-case scenarios, ensuring product safety and efficacy....
Read more >>
Cleaning Validation of Equipment in Pharmaceutical Industry

Cleaning Validation In the Pharmaceutical Industry

Explore the essentials of cleaning validation in the pharmaceutical industry, including all necessary steps, challenges, and regulatory standards....
Read more >>
GMP Insiders LOGO Inverted

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!